Portfolio
Eucalyptus

Eucalyptus

Year Invested:
2018
Stage:
Series A
Status:
Active

Eucalyptus is setting out to build a conglomerate of direct-to-consumer healthcare brands.

The company’s first product is Pilot, a medical advisor for a generation of young men that are poorly served by the medical community.

Their second company is Kin - who deliver the contraceptive pill your door.

Read our Eucalyptus Investment Notes.

Learn more about the story behind Eucalyptus in our Wild Hearts interview with co-founder Tim Doyle.


Back to portfolio